Please use this identifier to cite or link to this item: http://adhlui.com.ui.edu.ng/jspui/handle/123456789/2654
Full metadata record
DC FieldValueLanguage
dc.contributor.authorABUDU, O-
dc.contributor.authorROTIMI, V-
dc.contributor.authorUGURU, V-
dc.contributor.authorAGBOOLA, A-
dc.date.accessioned2024-08-14T09:46:09Z-
dc.date.available2024-08-14T09:46:09Z-
dc.date.issued1986-
dc.identifier.citationAfr. J. Med. med. Sci. (I986) 15, 35-40en_US
dc.identifier.issn1116-4077-
dc.identifier.urihttp://adhlui.com.ui.edu.ng/jspui/handle/123456789/2654-
dc.descriptionARTICLEen_US
dc.description.abstractUsing strict diagnostic criteria, a clinical trial of cefoxitin as the only antimicrobial agent in the treatment of twenty-five cases of septic abortion was carried out. T h e success rate of 777«» (seventeen out of twenty-two) was significant in this group of seriously ill patients of low social class. Presence of pelvic abscess doe s not seem to preclude the use of cefoxitin. While the infections were of mixed bacterial flora, anaerobes were the predominant organisms isolated. Most organisms isolated were sensitive to cefoxitin but Psemlonumas aeruginosa was markedly resistant. No untoward reactions were observed. It appears that cefoxitin was successful as a single agent in the treatment of septic abortionen_US
dc.description.sponsorshipCOLLEGE OF MEDICINEen_US
dc.language.isoenen_US
dc.publisherBLACKWELL SCIENTIFIC PUBLICATIONSen_US
dc.subjectAbortionen_US
dc.subjectSepticen_US
dc.subjectAntimicrobialen_US
dc.subjectCefoxitinen_US
dc.titleCefoxitin: single agent treatment of septic abortionen_US
dc.typeArticleen_US
Appears in Collections:African Journal of Medicine and Medical Sciences

Files in This Item:
File Description SizeFormat 
Abudu et al_Cefoxitin_1986.pdfARTICLE7.08 MBAdobe PDFView/Open


Items in COMUI (ADHL) are protected by copyright, with all rights reserved, unless otherwise indicated.